STE
Price
$222.89
Change
+$1.03 (+0.46%)
Updated
Nov 12, 03:37 PM (EDT)
85 days until earnings call
XRAY
Price
$17.52
Change
-$0.13 (-0.74%)
Updated
Nov 12, 03:41 PM (EDT)
106 days until earnings call
Ad is loading...

STE vs XRAY

Header iconSTE vs XRAY Comparison
Open Charts STE vs XRAYBanner chart's image
STERIS
Price$222.89
Change+$1.03 (+0.46%)
Volume$550
CapitalizationN/A
DENTSPLY SIRONA
Price$17.52
Change-$0.13 (-0.74%)
Volume$1.4K
CapitalizationN/A
STE vs XRAY Comparison Chart
Loading...
STE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
STE vs. XRAY commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STE is a Buy and XRAY is a Buy.

COMPARISON
Comparison
Nov 13, 2024
Stock price -- (STE: $221.86 vs. XRAY: $17.65)
Brand notoriety: STE and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: STE: 120% vs. XRAY: 171%
Market capitalization -- STE: $22.22B vs. XRAY: $6.69B
STE [@Medical Specialties] is valued at $22.22B. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STE’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • STE’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both STE and XRAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STE’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 4 bullish TA indicator(s).

  • STE’s TA Score: 4 bullish, 4 bearish.
  • XRAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, STE is a better buy in the short-term than XRAY.

Price Growth

STE (@Medical Specialties) experienced а -1.75% price change this week, while XRAY (@Medical Specialties) price change was -24.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.98%. For the same industry, the average monthly price growth was +3.00%, and the average quarterly price growth was -2.71%.

Reported Earning Dates

STE is expected to report earnings on Feb 05, 2025.

XRAY is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (+1.98% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($22.2B) has a higher market cap than XRAY($6.69B). STE has higher P/E ratio than XRAY: STE (38.85) vs XRAY (19.23). STE YTD gains are higher at: 1.615 vs. XRAY (-49.540). STE has higher annual earnings (EBITDA): 1.39B vs. XRAY (249M). XRAY has more cash in the bank: 334M vs. STE (196M). XRAY has less debt than STE: XRAY (2.3B) vs STE (3.51B). STE has higher revenues than XRAY: STE (5.41B) vs XRAY (3.97B).
STEXRAYSTE / XRAY
Capitalization22.2B6.69B332%
EBITDA1.39B249M560%
Gain YTD1.615-49.540-3%
P/E Ratio38.8519.23202%
Revenue5.41B3.97B136%
Total Cash196M334M59%
Total Debt3.51B2.3B153%
FUNDAMENTALS RATINGS
STE vs XRAY: Fundamental Ratings
STE
XRAY
OUTLOOK RATING
1..100
123
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
36100
SMR RATING
1..100
7990
PRICE GROWTH RATING
1..100
5965
P/E GROWTH RATING
1..100
6990
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for STE (78). This means that XRAY’s stock grew significantly faster than STE’s over the last 12 months.

STE's Profit vs Risk Rating (36) in the Medical Specialties industry is somewhat better than the same rating for XRAY (100). This means that STE’s stock grew somewhat faster than XRAY’s over the last 12 months.

STE's SMR Rating (79) in the Medical Specialties industry is in the same range as XRAY (90). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

STE's Price Growth Rating (59) in the Medical Specialties industry is in the same range as XRAY (65). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

STE's P/E Growth Rating (69) in the Medical Specialties industry is in the same range as XRAY (90). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STEXRAY
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 7 days ago
57%
Declines
ODDS (%)
Bearish Trend 15 days ago
47%
Bearish Trend 21 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
47%
Aroon
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
STE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRVN16.690.34
+2.11%
Driven Brands Holdings
UBFO9.230.16
+1.82%
United Security Bancshares
RRX176.301.24
+0.71%
Regal Rexnord Corp
VERB9.53-0.25
-2.56%
Verb Technology Company Inc
HOUS3.96-0.22
-5.26%
Anywhere Real Estate

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with BDX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then BDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
+1.22%
BDX - STE
48%
Loosely correlated
+1.28%
RVTY - STE
45%
Loosely correlated
-1.49%
EMBC - STE
45%
Loosely correlated
+1.48%
XRAY - STE
44%
Loosely correlated
-1.18%
QGEN - STE
43%
Loosely correlated
+0.66%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with KIDS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-1.18%
KIDS - XRAY
48%
Loosely correlated
-2.74%
HBIO - XRAY
46%
Loosely correlated
-4.67%
NVST - XRAY
44%
Loosely correlated
+1.77%
STE - XRAY
44%
Loosely correlated
+1.22%
ZBH - XRAY
43%
Loosely correlated
+1.18%
More